Implant prequalified by WHO Bayer Schering Pharma's Levonorgestrel two-rod implant receives WHO approval Better known by its brand name, Jadelle, the 2 rod (75 mg each) hormonal implant manufactured…
UAFC International Platform meeting October 6-7, 2009 in Amsterdam Members of the International Platform on Universal Access to Female Condoms (UAFC) will discuss the opportunities and challenges…
Launch of WomanCare Global Ipas announces new non-profit subsidiary focused on RH technologies WomanCare Global LLC, a new non-profit subsidiary of Ipas launched September 24th, 2009. Ipas is…
Concept Foundation introduces Medabon® Efforts underway to expand access Improving access to safe abortion services remains a public health imperative. A new product, Medabon®, is being made…
BlueStar proving a social franchising success MSI is setting an encouraging new trend: combining ambitious social service-provision goals with a franchise model, and targeted social…
BlueStar Ethiopia introduces medical abortion Addis Ababa - MSI Ethiopia has recently started taking medical abortion outside of its own centres through its growing BlueStar franchise network. Addis…
Young decision makers learn about RH supplies European youth attend a study tour in Uganda A delegation of 9 European Young Decision Makers in leadership positions within various youth political…
New summary from the "Access to RH Essential Medicines" forum Includes challenges and recommendations A summary of the recent online discussion forum, "Access to RH Essential Medicines: Why is…
Kenya reports shortage of contraceptives Up to 25% of women unable to access contraception Kenya is faced with a shortage of contraceptives due to over reliance on donors, according to Family Health…
New chart on EC availability A new chart reviews availability of various EC products in the US A chart created by Reproductive Health Technologies Project clarifies the current situation with…
